Kobi Tzoref
Kobi Tzoref is the CEO of Pharma Israel, an association representing international original drug companies. He has emphasized the importance of regulatory oversight for pharmaceutical distribution companies like Novolog amidst the unprecedented medication shortages affecting patients across Israel.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Israel | 1 | 9.00 | 0.04% | +0% | 9,216,900 | 3,653 | $400,000 | 159$ |
| Totals | 1 | 9,216,900 | 3,653 | $400,000 | 159$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Israel:
Kobi Tzoref, CEO of Pharma Israel, welcomed the reliance on international drug registrations as a significant step for Israeli citizens.
9
Israel:
Kobi Tzoref, CEO of Pharma Israel, emphasized the critical role of Novolog in the drug supply process.
5